Select your country
Select a country to go to the website of the respective STADA sales company.
Saudi Arabia (1)
The Phillippines (1)
United Arab Emirates (1)
United Kingdom (4)
Explore our news
The European Commission (EC) has granted conditional marketing authorization for Kinpeygo®
Self-assessed burnout rates at all-time high; stress levels have increased;
more than one in three are struggling with sleep; appreciation f…
Many Parkinson’s patients across Europe are missing out on regular specialist advice on treating their condition, according to the findings …
Offers a comprehensive range of presentations to the EU adalimumab
STADA has taken a significant step towards expanding its Specialty portfolio
Dr Christine Berndt joins STADA from June as Head of Global Development Specialties/Biosimilars
A citrate-free, high-concentration biosimilar to Humira® by resolving European patent dispute with AbbVie
Ignis and STADA’s Britannia sign exclusive licensing agreement to develop and commercialize subcutaneous apomorphine in mainland China, Hong…
STADA is preparing to meet demand for its expanding portfolio by investing almost EUR50 million in a supply-chain hub in Turda, Romania
Experienced expert Erin Federman will oversee commercialization of STADA’s biosimilars portfolio and pipeline
Half-year results 2021
Enzymatica has licensed to STADA exclusive rights to market and sell ViruProtect® (distributed by Enzymatica as ColdZyme®) in Vietnam.
What drives the company? STADA promotes its purpose with an emotional film stating, that health is at the heart of the company's everyday work. The video spotlights how each and every employee is aiming to improve people’s lives every day.
“Caring for People’s Health as a Trusted Partner” is STADA’s purpose and guides as a north star. The purpose is the foundation of all companies’ actions and unites all employees globally as a team. One STADA team with the aim: bringing health to society.